Metyrosine 1 5 g daily for 9 days decreased 24-h urine metanephrine concentration by about 60% in a patient with multiple catecholamine-secreting paragangliomas Despite the considerable inhibition of catecholanune synthesis, this patient exhibited stress-induced sympathetic overactivity, indicated by increases in arterial pressure and serum catecholamine and urine metanephrine concentrations. It is concluded that metyrosine should be introduced early to the preoperative regimen. In this way, optimal inhibitory effect on catecholamine synthesis can be obtained and maintained for a sufficient time to allow catecholamine stores to become as close to normal as possible Attainment of the optimal therapeutic effect is not dearly defined, but would seem to be best gauged by a combination of clinical tests of sympathetic responses and of suppression of urinary excretion of metanephrines or VMA.
I
The purpose of preoperative preparation of patients with catecholamine-secreting tumours is to protect them from the effects of an excess of catecholamines and to ensure a safe perioperative course. Adrenergic blocking drugs, such as phenoxybenzamine and propranolol, have been useful in reducing the effects of catecholamine excess before and during operation.
Another approach to the preoperative preparation of patients with catecholamine-secreting tumours would seem to be to decrease the rate of catecholamine synthesis with metyrosine (alphamethyl-para tyrosine). This tyrosine analogue is an inhibitor of tyrosine hydroxylase, which catalyses the rate-limiting step in catecholamine synthesis, namely the conversion of tyrosine to dihydroxy phenylalanine (dopa). We report the use of metyrosine in the pre-and intra-operative management of a patient with multifocal catecholaminesecreting paragangliomas.
CASE REPORT
A 53-year-old white male developed labile hyperten-sion in 1970. In 1977, he underwent investigation and functional cervical and abdominal paragangliomas vere diagnosed. Subsequently, the abdominal paraganglioma was removed. The cervical paranganglioma was judged to be inoperable and was treated with radiotherapy. The 24-h urine metanephrine concentration remained increased at 5.5mg/24h (normal =< 1 mg/24 h), while the labile hypertension was partially controlled (140-150/90-110 mm Hg) with oral propranolol 20 mg and phenoxybenzamine 10 mg, three times daily.
Four years later, the patient was admitted to hospital for surgical correction of a right inguinal hernia. Labile hypertension was again noted, with marked increases of 24-h urine metanephrine concentrations ( fig. 1 ). X-rays revealed a right rib abnormality and bone scan showed several rib and left femoral "hot spots". Subsequent rib biopsy demonstrated paranganglioma tissue. As the inguinal hernia interfered with walking, it was decided to proceed with surgery.
Oral propranolol 20 mg and phenoxybenzamine lOmg four times daily were continued and, on the ninth day before surgery, oral metyrosine was added to the regimen. The dose was rapidly increased to 500 mg three times daily. Vital signs were observed closely and sequential 24-h urine samples were collected for metanephrine determinations ( fig. 1 ). When good control of arterial pressure and a substantial decrease in urine metanephrine excretion were achieved, the patient was considered to be BRITISH JOURNAL OF ANAESTHESIA satisfactorily prepared for surgery. Premedication consisted of pethidine 75mg and hydroxyzine 50 mg i.m. Two peripheral intravenous and a radial artery catheter were inserted.
On his arrival in the operating room, the patient's arterial pressure was increased (200-210/90-110 mmHg) and his pulse was 70-80beatmin~'. Anaesthesia consisted of a continuous lumbar extradural block with 1.5% carbocaine (total volume, 28 ml). Throughout surgery the level of analgesia remained at T4-T10 and the patient was free of pain and discomfort. Sedation was accomplished with pethidine (total 40mgi.v.). Arterial pressure remained increased and intermittent sodium nitroprusside infusion was required for its control. Total serum catecholamine concentrations were increased before and markedly during surgery ( fig. 2 ). Urine metanephrine concentrations were also increased for 48 h after operation and then began to decrease ( fig. 1 ). Arterial pressure changes during the period after operation generally followed the changes in urine metanephrines, which apparently reflected an excess of catecholamine release.
The patient had an uneventful postoperative course and was discharged with a continuing regimen of propranolol 20 mg and phenoxybenzamine 10 mg four times daily, and metyrosine 500 mg three times daily.
DISCUSSION
This report illustrates some of the problems encountered in patients with catecholamine-secreting tumours. It was evident at the time of the patient's admission that he had signs and symptoms of uncontrolled catecholamine excess. Indeed, 24-h urinary The management of this patient is instructive regarding the attainment of optimal benefit from metyrosine. Despite a 50-60% decrease in urinary metanephrine excretion associated with significant improvement in arterial pressure control, clinical and laboratory evidence of stress-induced sympathetic overactivity was seen on two occasions ( fig. 1) . The first was related to the performance of a rib biopsy under local anaesthesia. The second episode occurred on the day of surgery. These responses probably represent the effects of catecholamines released from tumour tissues and from peripheral stores.
Our experience indicates that attainment of normal or near normal arterial pressure, heart rate and urinary excretion of catecholamines or metanephrines, under relatively non-stressful conditions, is not a reliable predictive index of the subsequent intraoperative course. It remains to be determined if metyrosine at greater doses and maintained for longer periods would render normal the rate of catecholamine synthesis and prevent release of excess catecholamines during surgery. A review of the literature indicates that, when used alone or in combination with adrenergic blockade, metyrosine is of value in protecting patients with catecholamine-secreting tumours from the deleterious effects of catecholamine excess (Sjoerdsma et al., 1965; Sjoerdsma et al., 1966; Jones et al., 1968; Bagnall, Salway and Jackson, 1976; Robinson et al., 1977; Hengstmann, Gugler and Dengler, 1979) . One would expect that administration of metyrosine before operation should ensure a smoother course during surgery. However, available data do not permit a definitive conclusion (Sjoerdsma et al., 1966; Jones et al., 1968; Tcherdakoff et al., 1972; Bagnall, Salway and Jackson, 1976; Robinson et al., 1977; Bergman et al., 1978; Smith, Aukburg and Levitt, 1978; Hengstmann, Gugler and Dengler, 1979) . As a result of our observations, we feel that different degrees of catecholamine synthesis suppression were achieved in the reported studies and this may account for the mixed clinical impressions reported. It is known that the degree of metyrosine inhibition of catecholamine synthesis is dose related and that there is variation in the amount required to achieve a given degree of inhibition (Sjoerdsma et al., 1965; Jones etal., 1968) .
We believe that preoperative metyrosine should be introduced early so that the optimal effect can be obtained, usually in 7-10 days (Engelman, 1977) and maintained sufficiently long to achieve as much normalization of catecholamine stores as is possible. While the duration of this period cannot be predicted at present, it can be estimated from the data of Hengstmann and Dengler (1978) that, even with complete inhibition of excess catecholamine synthesis, normalization of catecholamine stores could take from 1 week to 50 days (four to five half-lives). More information is needed regarding the clinical and laboratory criteria most helpful in predicting the attainment of this goal, which presently would seem to be best gauged by a combination of clinical tests of sympathetic responses and the suppression of urinary excretion of metanephrines or VMA.
UTILISATION DE LA METYROSINE DANS LE PROTOCOLE ANESTHESIQUE DE PATIENTS AYANT DES TUMEURS SECRET ANT DES CATECHOLAMINES
A prapos d'un cat RESUME L'utilisation de metyrosine 1,5 mg par jour pendant 9 jours, a diminue la concentration urinaire des 24 h de mitanephrine d'environ 60% chez un patient porteur de paragangliomes multiples secretant des catecholamines. Malgre une inhibition considerable de la synthfcse des catecholamines, ce patient objectivait une hyperactivite sympathique liee au »tress, qui se traduisait par une elevation de la pression artenelle, det catecholamines seriques et de la concentration urinaire de metanephrine. Nous en conduons que le metyrosine devrait etre introduite de fajon precoce. dans la preparation a l'intervention. De cette facon, on 
SUMARIO
La administraci6n de l,5gramos de metirosina dianos por espado de 9 dias disminuy6 en aprozimadamente el 60% la concentraci6n de metanefrina en la orina en un ciclo de 24horas, en un paciente con paragangliomas multiples que segregaban catecolamina. A pesar de la considerable inhibicidn de la sintesis de catecolamina, este paciente mostro Una sobreactividad del sistema simpauco inducida por la tension, que se puso de manifesto por un aumento de la presi6n arterial y por la concentraci6n de catecolamina en el suero y en la de mentanefrina en la orina. Se conduye que la metirosina debe mtroducirse en el regimen preoperativo en sus primeras fases. De esta forma pueden obtenerse y mantenerse los ef ectos inhibitorios 6ptimoj de la sintesis de la catecolamina durante el suficiente espacio de tiempo para permitir que el almacenamiento de esta se acerque lo mas posible a lo normal. La obtencion del efecto terapeutico dptimo no esta daramente definido, pero parece que se mediria mejor mediante una combination de pruebas clinicas de las respuestas del sistema simpitico y de supresion de metanefrinas en la excretion urinana ordeVMA.
